|
1
|
Eeson G, Cleary S, Moulton CAE and Ridgway
PF: Ampullary cancer. Springer International Publishing; 2016
|
|
2
|
Okano K, Oshima M, Yachida S, Kushida Y,
Kato K, Kamada H, Wato M, Nishihira T, Fukuda Y, Maeba T, et al:
Factors predicting survival and pathological subtype in patients
with ampullary adenocarcinoma. J Surg Oncol. 110:56–162. 2014.
View Article : Google Scholar
|
|
3
|
Tian Y, Wu SD, Chen YS and Chen CC:
Transumbilical single-incision laparoscopic cholecystojejunostomy
using conventional instruments: The first two cases. J Gastrointest
Surg. 14:1429–1433. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kondo S, Takada T, Miyazaki M, Miyakawa S,
Tsukada K, Nagino M, Furuse J, Saito H, Tsuyuguchi T, Yamamoto M,
et al: Guidelines for the management of biliary tract and ampullary
carcinomas: Surgical treatment. J Hepatobiliary Pancreat Surg.
15:41–54. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yokoyama N, Shirai Y, Wakai T, Nagakura S,
Akazawa K and Hatakeyama K: Jaundice at presentation heralds
advanced disease and poor prognosis in patients with ampullary
carcinoma. World J Surg. 29:519–523. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Robert PE, Leux C, Ouaissi M, Miguet M,
Paye F, Merdrignac A, Delpero JR, Schwarz L, Carrere N, Muscari F,
et al: Predictors of long-term survival following resection for
ampullary carcinoma: A large retrospective French multicentric
study. Pancreas. 43:692–697. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Smith RA, Ghaneh P, Sutton R, Raraty M,
Campbell F and Neoptolemos JP: Prognosis of resected ampullary
adenocarcinoma by preoperative serum CA19-9 levels and
platelet-lymphocyte ratio. J Gastrointest Surg. 12:1422–1428. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao X, Dong J, Huang X, Zhang W and Jiang
K: Prognostic factors for survival of patients with ampullary
carcinoma after local resection. ANZ J Surg. 85:567–571. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mann DV, Edwards R, Ho S, Lau WY and
Glazer G: Elevated tumour marker CA19-9: Clinical interpretation
and influence of obstructive jaundice. Eur J Surg Oncol.
26:474–479. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ker CG, Chen JS, Lee KT, Sheen PC and Wu
CC: Assessment of serum and bile levels of CA19-9 and CA125 in
cholangitis and bile duct carcinoma. J Gastroenterol Hepatol.
6:505–508. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kau SY, Shyr YM, Su CH, Wu CW and Lui WY:
Diagnostic and prognostic values of CA 19-9 and CEA in
periampullary cancers. J Am Coll Surg. 188:415–420. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Au KK, Josahkian JA, Francis JA, Squire JA
and Koti M: Current state of biomarkers in ovarian cancer
prognosis. Future Oncol. 11:3187–3195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhu L, Li X, Shen Y, Ying C, Fang X, Chen
J and Ying Y: A new prognostic score based on the systemic
inflammatory response in patients with inoperable non-small-cell
lung cancer. Onco Targets Ther. 9:4879–4886. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Namikawa T, Munekage E, Munekage M, Maeda
H, Yatabe T, Kitagawa H, Kobayashi M and Hanazaki K: Evaluation of
systemic inflammatory response biomarkers in patients receiving
chemotherapy for unresectable and recurrent advanced gastric
cancer. Oncology. 90:338–326. 2016. View Article : Google Scholar
|
|
15
|
Dreyer SB, Powell AG, Mcsorley ST,
Waterston A, Going JJ, Edwards J, Mcmillan DC and Horgan PG: The
pretreatment systemic inflammatory response is an important
determinant of poor pathologic response for patients undergoing
neoadjuvant therapy for rectal cancer. Ann Surg Oncol.
24:1295–1303. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Geng Y, Qi Q, Sun M, Chen H, Wang P and
Chen Z: Prognostic nutritional index predicts survival and
correlates with systemic inflammatory response in advanced
pancreatic cancer. Eur J Surg Oncol. 41:1508–1514. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Asher V, Lee J, Innamaa A and Bali A:
Preoperative platelet lymphocyte ratio as an independent prognostic
marker in ovarian cancer. Clin Transl Oncol. 13:499–503. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou X, Xu L, Huang Z, Zhang L, Zhang H,
Zhu W and Liu P: The hematologic markers as prognostic factors in
patients with resectable gastric cancer. Cancer Biomark.
17:359–367. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schlieman MG, Ho HS and Bold RJ: Utility
of tumor markers in determining resectability of pancreatic cancer.
Arch Surg. 138:951–956. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Connor S, Bosonnet L, Alexakis N, Raraty
M, Ghaneh P, Sutton R and Neoptolemos JP: Serum CA19-9 measurement
increases the effectiveness of staging laparoscopy in patients with
suspected pancreatic malignancy. Dig Surg. 22:80–85. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mahul BA, Stephen E, Frederick G, David
RB, Robert KB, Mary KW, Jeffrey EG, Carolyn CC, Kenneth RH, Daniel
CS, et al: AJCC cancer staging manual. 8th. New York: Springer;
2017
|
|
22
|
Yuan J, Zhou J, Dong Z, Tandon S, Kuk D,
Panageas KS, Wong P, Wu X, Naidoo J, Page DB, et al: Pretreatment
serum VEGF is associated with clinical response and overall
survival in advanced melanoma patients treated with ipilimumab.
Cancer Immunol Res. 2:127–132. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hothorn T and Lausen B: On the exact
distribution of maximally selected rank statistics. Comput Stat
Data Anal. 43:121–137. 2003. View Article : Google Scholar
|
|
24
|
Lian L, Xia YY, Zhou C, Shen XM, Li XL,
Han SG, Zheng Y, Mao ZQ, Gong FR, Wu MY, et al: Application of
platelet/lymphocyte and neutrophil/lymphocyte ratios in early
diagnosis and prognostic prediction in patients with resectable
gastric cancer. Cancer Biomark. 15:899–907. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Martin HL, Ohara K, Kiberu A, Van Hagen T,
Davidson A and Khattak MA: Prognostic value of systemic
inflammation-based markers in advanced pancreatic cancer. Intern
Med J. 44:676–682. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lausen B and Schumacher M: Maximally
selected rank statistics. Biometrics. 48:3–85. 1992. View Article : Google Scholar
|
|
27
|
Haruki K, Shiba H, Horiuchi T, Shirai Y,
Iwase R, Fujiwara Y, Furukawa K, Misawa T and Yanaga K: Neutrophil
to lymphocyte ratio predicts therapeutic outcome after
pancreaticoduodenectomy for carcinoma of the ampulla of vater.
Anticancer Res. 36:403–408. 2016.PubMed/NCBI
|
|
28
|
Demirci NS and Erdem GU: Prognostic role
of the neutrophil-to-lymphocyte ratio (NLR) in patients with
operable ampullary carcinoma. Bosn J Basic Med Sci. Nov
13–2017.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mei Z, Shi L, Wang B, Yang J, Xiao Z, Du
P, Wang Q and Yang W: Prognostic role of pretreatment blood
neutrophil-to-lymphocyte ratio in advanced cancer survivors: A
systematic review and meta-analysis of 66 cohort studies. Cancer
Treat Rev. 58:1–13. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cheng H, Long F, Jaiswar M, Yang L, Wang C
and Zhou Z: Prognostic role of the neutrophil-to-lymphocyte ratio
in pancreatic cancer: A meta-analysis. Sci Rep. 5:110262015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pang W, Lou N, Jin C, Hu C, Arvine C, Zhu
G and Shen X: Combination of preoperative platelet/lymphocyte and
neutrophil/lymphocyte rates and tumor-related factors to predict
lymph node metastasis in patients with gastric cancer. Eur J
Gastroenterol Hepatol. 28:493–502. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ertas IE, Gungorduk K, Akman L, Ozdemir A,
Terek MC, Ozsaran A, Sanci M and Dikmen Y: Can preoperative
neutrophil:lymphocyte and platelet:lymphocyte ratios be used as
predictive markers for lymph node metastasis in squamous cell
carcinoma of the vulva? Eur J Obstet Gynecol Reprod Biol.
171:138–142. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Suh DH, Kim HS, Chung HH, Kim JW, Park NH,
Song YS and Kang SB: Pre-operative systemic inflammatory response
markers in predicting lymph node metastasis in endometrioid
endometrial adenocarcinoma. Eur J Obstet Gynecol Reprod Biol.
162:206–210. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Asher V, Lee J and Bali A: Preoperative
serum albumin is an independent prognostic predictor of survival in
ovarian cancer. Med Oncol. 29:2005–2009. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Supoken A, Kleebkaow P, Chumworathayi B,
Luanratanakorn S and Kietpeerakool C: Elevated preoperative
platelet to lymphocyte ratio associated with decreased survival of
women with ovarian clear cell carcinoma. Asian Pac J Cancer Prev.
15:10831–10836. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang WW, Liu KJ, Hu GL and Liang WJ:
Preoperative platelet/lymphocyte ratio is a superior prognostic
factor compared to other systemic inflammatory response markers in
ovarian cancer patients. Tumor Biol. 36:8831–8837. 2015. View Article : Google Scholar
|
|
37
|
Nakamura K, Nagasaka T, Nishida T, Haruma
T, Ogawa C, Kusumoto T, Seki N and Hiramatsu Y: Neutrophil to
lymphocyte ratio in the pre-treatment phase of final-line
chemotherapy predicts the outcome of patients with recurrent
ovarian cancer. Oncol Lett. 11:3975–3981. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fan F, Tian Y, Liu S, Zheng G, Zhen L, Xu
G, Man G, Xiao L, Fan D and Zhang H: Combination of PLR, MLR, MWR,
and tumor size could significantly increase the prognostic value
for gastrointestinal stromal tumors. Medicine (Baltimore).
95:e32482016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yokoigawa N, Takeuchi N, Toda M, Inoue M,
Kaibori M, Yanagida H, Tanaka H, Ogura T, Takada H, Okumura T, et
al: Enhanced production of interleukin 6 in peripheral blood
monocytes stimulated with mucins secreted into the bloodstream.
Clin Cancer Res. 11:6127–6132. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yokoigawa N, Takeuchi N, Toda M, Inoue M,
Kaibori M, Yanagida H, Inaba T, Tanaka H, Ogura T, Takada H, et al:
Overproduction of PGE2 in peripheral blood monocytes of
gastrointestinal cancer patients with mucins in their bloodstream.
Cancer Lett. 245:149–155. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kannagi R, Izawa M, Koike T, Miyazaki K
and Kimura N: Carbohydrate-mediated cell adhesion in cancer
metastasis and angiogenesis. Cancer Sci. 95:377–384. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Honn KV, Tang DG and Crissman JD:
Platelets and cancer metastasis: A causal relationship? Cancer
Metastasis Rev. 11:325–351. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hussain SP and Harris CC: Inflammation and
cancer: An ancient link with novel potentials. Int J Cancer.
121:2373–2380. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sotomayor EM, Fu YX, Lopezcepero M,
Herbert L, Jimenez JJ, Albarracin C and Lopez DM: Role of
tumor-derived cytokines on the immune system of mice bearing a
mammary adenocarcinoma. II. Down-regulation of macrophage-mediated
cytotoxicity by tumor-derived granulocyte-macrophage
colony-stimulating factor. J Immunol. 147:2816–2823.
1991.PubMed/NCBI
|
|
45
|
Rachidi S, Metelli A, Riesenberg B, Wu BX,
Nelson MH, Wallace C, Paulos CM, Rubinstein MP, Garrettmayer E,
Hennig M, et al: Platelets subvert T cell immunity against cancer
via GARP-TGFβ axis. Sci Immunol. 2:pii: eaai79112017. View Article : Google Scholar
|
|
46
|
Kim EY, Lee JW, Yoo HM, Park CH and Song
KY: The platelet-to-lymphocyte ratio versus
neutrophil-to-lymphocyte ratio: Which is better as a prognostic
factor in gastric cancer? Ann Surg Oncol. 22:4363–4370. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhang X and Ran Y: Prognostic role of
elevated platelet count in patients with lung cancer: A systematic
review and meta-analysis. Int J Clin Exp Med. 8:5379–5387.
2015.PubMed/NCBI
|
|
48
|
Ishizuka M, Nagata H, Takagi K, Iwasaki Y
and Kubota K: Combination of platelet count and neutrophil to
lymphocyte ratio is a useful predictor of postoperative survival in
patients with colorectal cancer. Br J Cancer. 109:401–407. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
O'Byrne KJ, Dobbs N, Propper D, Smith K
and Harris AL: Vascular endothelial growth factor platelet counts,
and prognosis in renal cancer. Lancet. 353:1494–1495. 1999.
View Article : Google Scholar
|
|
50
|
Quigley DA and Kristensen V: Predicting
prognosis and therapeutic response from interactions between
lymphocytes and tumor cells. Mol Oncol. 9:2054–2062. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Templeton AJ, Mcnamara MG, Šeruga B,
Vera-Badillo FE, Aneja P, Ocaña A, Leibowitz-Amit R, Sonpavde G,
Knox JJ, Tran B, et al: Prognostic role of neutrophil-to-lymphocyte
ratio in solid tumors: a systematic review and meta-analysis. J
Natl Cancer Inst. 106:dju1242014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Huang C, Jie Y, Li Z, Na L, Zhao J and Qi
D: Usefulness of the neutrophil-to-lymphocyte ratio in predicting
lymph node metastasis in patients with non-small cell lung cancer.
Tumor Biol. 36:7581–7589. 2015. View Article : Google Scholar
|
|
53
|
Sewnath ME, Karsten TM, Prins MH, Rauws
EJ, Obertop H and Gouma DJ: A meta-analysis on the efficacy of
preoperative biliary drainage for tumors causing obstructive
jaundice. Ann Surg. 236:17–27. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Povoski SP, Karpeh MS Jr, Conlon KC,
Blumgart LH and Brennan MF: Preoperative biliary drainage: Impact
on intraoperative bile cultures and infectious morbidity and
mortality after pancreaticoduodenectomy. J Gastrointest Surg.
3:496–505. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Barauskas G, Urbonas K, Smailyte G, Pranys
D, Pundzius J and Gulbinas A: Preoperative endoscopic biliary
drainage may negatively impact survival following
pancreatoduodenectomy for ampullary cancer. Dig Surg. 33:462–469.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Tank AK, Singh RK, Prakash A, Behari A,
Kumar A, Saxena R and Kapoor VK: Adjuvant therapy does not improve
survival of ampullary carcinoma patients. Gastrointest Cancer Res.
Suppl 1:S312010.
|
|
57
|
Evans DB, Wolff RA and Hess KR: Adjuvant
radiotherapy and 5-fluorouracil after curative resection of cancer
of the pancreas and periampullary region. Ann Surg. 230:776–784.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Furuse J, Takada T, Miyazaki M, Miyakawa
S, Tsukada K, Nagino M, Kondo S, Saito H, Tsuyuguchi T, Hirata K,
et al: Guidelines for chemotherapy of biliary tract and ampullary
carcinomas. J Hepatobiliary Pancreat Surg. 15:55–62. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Yamaguchi K and Enjoji M: Carcinoma of the
ampulla of vater. A clinicopathologic study and pathologic staging
of 109 cases of carcinoma and 5 cases of adenoma. Cancer.
59:506–515. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Knox RA and Kingston RD: Carcinoma of the
ampulla of Vater. Br J Surg. 73:72–73. 1986. View Article : Google Scholar : PubMed/NCBI
|
